BioControl Medical

Therapeutic Devices for Autonomic Disorders

BioControl Medical develops advanced active implantable medical devices for the treatment of autonomic disorders, conditions whereby the autonomic nervous system ceases to function properly, resulting in a disruption to the control of involuntary body processes. The devices enable controlled electrical stimulation of various nerves to achieve therapeutic results.

BioControl Medical has developed the CardioFit® System, intended to effectively treat heart failure via vagus nerve stimulation. It has received the CE mark (2008) and is being studied under Investigational Device Exemption in the U.S.

Introducing INOVATE-HF


INOVATE-HF is a worldwide clinical trial designed to evaluate the safety and efficacy of a treatment for heart failure. 

Do you qualify for INOVATE-HF clinical trial?

Patients & Families

Click here for more information.

Health Professionals

Click here for more information.

Latest News & Events

Jan. 9, 2012
Medtronic pines for medical device innovation in Israel

Jun. 14, 2011
CerebralRX Enters Global Neuromodulation Market with the FitNeS™ System for Treating Epilepsy

May. 23-25, 2011
ILSI BioMed Israel 2011

Apr. 26, 2011
BioControl Medical Launches the INOVATE-HF IDE Study of its CardioFit® System for Heart Failure

Investigators Login